Literature DB >> 17157132

Topography-guided surface ablation for forme fruste keratoconus.

Tobias Koller1, Hans Peter Iseli, Christof Donitzky, Dipl Ing, Nikolaos Papadopoulos, Theo Seiler.   

Abstract

PURPOSE: To evaluate the efficacy of customized surface ablation in cases of forme fruste keratoconus.
DESIGN: Prospective noncomparative case series. PARTICIPANTS: Eleven eyes of 8 contact lens-intolerant patients with forme fruste keratoconus treated at the Institute of Refractive and Ophthalmic Surgery and the University Eye Clinic Zurich. INTERVENTION: Topography-guided customized surface ablation by means of a scanning spot excimer laser. MAIN OUTCOME MEASURES: Visual acuity, refraction, quality of vision (ghosting), corneal topography including the Zernike parameter Z3.
RESULTS: Statistically significant reduction of manifest refractive error, corneal irregularity, and ghosting. The spherical equivalent was reduced by -2.8+/-0.62 diopters (D) (P = 0.0007), the cylinder by 1.34 +/- 0.18 D (P = 0.015), Z3 was reduced by 41% (P<0.001), and all patients had less ghosting compared to their preoperative status. No eye lost > or =1 lines in best spectacle-corrected visual acuity; however, 7 of 11 eyes gained > or = 1 line.
CONCLUSION: Topography-guided surface ablation is a promising option to rehabilitate vision in contact lens-intolerant patients with forme fruste keratoconus.

Entities:  

Mesh:

Year:  2006        PMID: 17157132     DOI: 10.1016/j.ophtha.2006.06.032

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  13 in total

1.  Topographic typology in a consecutive series of refractive surgery candidates.

Authors:  Seyed-Farzad Mohammadi; Vahid Mohammadzadeh; Sakineh Kadivar; Amir-Houshang Beheshtnejad; Amir Hossein Norooznezhad; Seyed-Hassan Hashemi
Journal:  Int Ophthalmol       Date:  2017-07-04       Impact factor: 2.031

Review 2.  [Treatment indications for corneal crosslinking and clinical results of new corneal crosslinking techniques].

Authors:  Klara Borgardts; Johannes Menzel-Severing; Gerd Geerling; Theo G Seiler
Journal:  Ophthalmologe       Date:  2022-02-11       Impact factor: 1.059

Review 3.  Current review and a simplified "five-point management algorithm" for keratoconus.

Authors:  Rohit Shetty; Luci Kaweri; Natasha Pahuja; Harsha Nagaraja; Kareeshma Wadia; Chaitra Jayadev; Rudy Nuijts; Vishal Arora
Journal:  Indian J Ophthalmol       Date:  2015-01       Impact factor: 1.848

4.  Photorefractive keratectomy in mild to moderate keratoconus: outcomes in over 40-year-old patients.

Authors:  Hamid Khakshoor; Fatemeh Razavi; Alireza Eslampour; Arash Omdtabrizi
Journal:  Indian J Ophthalmol       Date:  2015-02       Impact factor: 1.848

Review 5.  Surgical Options for the Refractive Correction of Keratoconus: Myth or Reality.

Authors:  L Fernández-Vega-Cueto; V Romano; R Zaldivar; C H Gordillo; F Aiello; D Madrid-Costa; J F Alfonso
Journal:  J Ophthalmol       Date:  2017-12-18       Impact factor: 1.909

6.  Outcomes of photorefractive keratectomy in patients with posterior corneal steepening.

Authors:  Yumna Busool Abu-Eta; Achia Nemet; Igor Vainer; Michael Mimouni; Tzahi Sela; Gur Munzer; Igor Kaiserman
Journal:  Eye (Lond)       Date:  2020-10-06       Impact factor: 4.456

7.  Photorefractive Keratectomy in Keratoconus.

Authors:  Deepali Sandeep Tambe; Anders Ivarsen; Jesper Hjortdal
Journal:  Case Rep Ophthalmol       Date:  2015-08-05

8.  Photorefractive keratectomy in patients with mild to moderate stable keratoconus: a five-year prospective follow-up study.

Authors:  Elias Chelala; Hala El Rami; Ali Dirani; Ali Fadlallah; Omar Fakhoury; Elias Warrak
Journal:  Clin Ophthalmol       Date:  2013-09-26

9.  Transepithelial photorefractive keratectomy with crosslinking for keratoconus.

Authors:  Achyut N Mukherjee; Vasilis Selimis; Ioannis Aslanides
Journal:  Open Ophthalmol J       Date:  2013-10-18

Review 10.  Updates on corneal collagen cross-linking: Indications, techniques and clinical outcomes.

Authors:  Mehrdad Mohammadpour; Ahmad Masoumi; Masoud Mirghorbani; Kianoosh Shahraki; Hassan Hashemi
Journal:  J Curr Ophthalmol       Date:  2017-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.